Activators and Inhibitors of NRF2: A Review of Their Potential for Clinical Development

The transcription factor NRF2 (nuclear factor erythroid 2-related factor 2) triggers the first line of homeostatic responses against a plethora of environmental or endogenous deviations in redox metabolism, proteostasis, inflammation, etc. Therefore, pharmacological activation of NRF2 is a promising...

Descripción completa

Detalles Bibliográficos
Autores principales: Robledinos-Antón, Natalia, Fernández-Ginés, Raquel, Manda, Gina, Cuadrado, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6664516/
https://www.ncbi.nlm.nih.gov/pubmed/31396308
http://dx.doi.org/10.1155/2019/9372182

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6664516/
https://www.ncbi.nlm.nih.gov/pubmed/31396308
http://dx.doi.org/10.1155/2019/9372182

Ejemplares similares